States Can Use the Coronavirus Response to Go After Insulin Price Gougers

The COVID-19 healthcare crisis is spreading beyond just those with the virus. As millions of Americans lose their jobs, they also stand to lose the employer-provided health insurance they rely on for life-saving drugs. Without insurance, the costs of those drugs can skyrocket. Insulin alone can cost $12,000 a year. So what can be done to keep insulin affordable during the crisis? One solution might come from a novel legal strategy that would test the limits of what constitutes illegal price gouging.